Inventor · disambiguated record
Shaobao Wang
Also filed as: WANG SHAOBAO
5 granted patents·2 pending applications·2 citations·filing 2014–2022
63Inventor score
Files withJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD3SHANGHAI HANSOH BIOMEDICAL CO LTD3YOUNGENE THERAPEUTICS CO LTD1
Top patents by PatentIndex Score
7 records- 0167US10428081B2EGFR inhibitor, preparation method and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2018·Granted Oct 1, 2019·1 cites·20 claims
- 0263US10259820B2EGFR inhibitor, preparation method and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2015·Granted Apr 16, 2019·1 cites·28 claims
- 0353US2024228490A1Heterocyclic derivative inhibitor and preparation method therefor and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 0439US11136324B2Substituted imidazoles as apoptosis signal regulating kinase 1 inhibitorsJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Oct 5, 2021·0 cites·18 claims
- 0539US2021221822A1Tricyclic derivatives inhibitor, preparation method, and applications thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Application pending·0 cites
- 0637US11667631B2FGFR4 inhibitor, preparation method therefor, and applications thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Jun 6, 2023·0 cites·16 claims
- 0735US10011627B2C-aryl glucoside derivative, preparation methods thereof, and medical applications thereofYOUNGENE THERAPEUTICS CO LTD·Filed 2014·Granted Jul 3, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Shaobao Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →